Diazirine‐tagged systems are considered reliable compounds for photoaffinity labeling (PAL) in biochemical studies as they enable investigation and understanding of biological mechanisms through covalent bonding to the target and subsequent detection. 14 C‐labeled 4‐(3‐trifluoromethyl‐3 H ‐diazirin‐3‐yl)benzoic acid ( 11 ) was prepared by a lithium‐bromide exchange on the bis‐silylated 4‐bromophenyldiaziridine 19 with subsequent transformations with electrophiles as key steps of the synthesis. Using 14 CO 2 , which was generated from rather inexpensive Ba 14 CO 3 , the desired diaziridinylbenzoic acid 21 was obtained in 78 % yield based on the employed radioactive material. Oxidation under mild conditions then yielded diazirine 11 in a 100 mg scale. This versatile photoaffinity label was selectively attached to the tetrahydropyrane ring of bafilomycin A 1 ( 2 ) and concanamycin A‐derived 3 , which both specifically inhibit the V‐ATPases. Inhibition assays were performed and revealed that the inhibitory capacities of the labeled derivatives are suitable for PAL studies on this important group of enzymes to elucidate the as yet unknown binding sites. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
No takes yet. Share an insight, caveat, or question.
Bender et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: